ACA Therapeutics is a clinical-stage biopharmaceutical company dedicated to resolving the fundamental drivers of cancer and chronic diseases. Unlike traditional models focused on lifelong symptom management, we utilize our proprietary Upstream-Midstream-Downstream (UMD) Framework to restore systemic health.

Our mission is to deliver “The People’s Science”—accessible, high-potency therapies that target the root causes of illness. By leveraging repurposed science, we aim to drastically reduce drug costs and systemic toxicity, making life-saving treatments a reality for all patients, not just a privileged few.